Goal Attainment Scaling in Upper Limb Spasticity Treatment With Botulinum Toxin and the Influence of Regular Exercise for Spastic Upper Limb on Quality of Life in Patients After Stroke

What this Trial Is About

This research aims to evaluate goal attainment and the effects of regular exercise on health-related quality of life in patients after stroke who have upper limb spasticity treated with botulinum toxin-A (BTX-A). The study involves patients diagnosed with ischemic or hemorrhagic stroke and focuses on assessing motor function and goal achievement following BTX-A treatment. It is conducted in two parts to better understand how exercise impacts recovery and quality of life in this population. In the first part of the study, patients set specific, measurable, achievable, realistic, and time-bound (SMART) goals together with their physician, which are then assessed using the Goal Attainment Scale - Light before and two weeks after BTX-A application. After this, patients are randomized into two groups: one follows a prescribed exercise program consisting of active or passive exercises, including functional electrical stimulation, for two weeks; the other group exercises at their own discretion during the same period. Both groups keep an exercise diary during the second part. Participants will undergo comprehensive assessments of motor functioning including range of motion, spasticity, pain, motor disability, and daily activity dependence at baseline, after two weeks, and at the end of the four-week study. Health-related quality of life is measured at the start and end of the exercise period. Researchers will evaluate goal attainment and quality of life changes, with ongoing monitoring during the study. Total participation includes initial assessment, two-week BTX-A follow-up, and a further two-week exercise intervention phase.

Goal Attainment Scaling in Upper Limb Spasticity Treatment